Cant Elena Insider Trades

Insider Trading History

Track insider trading activity for Cant Elena. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Societal CDMO
Societal CDMO SCTL
Director
Holding Value $0 0 shares
Last Trade
Apr 08, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$101k 100,849 shares
$1.00
$1.10
Societal CDMO
Societal CDMO SCTL
Director
Holding Value $81k 73,620 shares
Last Trade
Apr 08, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$33k 30,000 shares
$1.10
$1.10
Recro Pharma
Recro Pharma REPH
Director
Holding Value $217k 103,620 shares
Last Trade
Aug 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$62.7k 30,000 shares
$2.09
$2.09
Societal CDMO
Societal CDMO SCTL
Director
Holding Value $114k 103,620 shares
Last Trade
Aug 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12k 30,000 shares
$0.40
$1.10
Recro Pharma
Recro Pharma REPH
Director
Holding Value $154k 73,620 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.9k 27,229 shares
$2.09
$2.09
Societal CDMO
Societal CDMO SCTL
Director
Holding Value $81k 73,620 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.1k 27,229 shares
$0.74
$1.10
Societal CDMO
Societal CDMO SCTL
Director
Holding Value $22k 20,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.6k 40,000 shares
$1.24
$1.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up